Choosing appropriate analysis methods for cluster randomised cross-over trials with a binary outcome

Statistics in Medicine

Volumn 36, Issue 2, 2017, Pages 318-333

  Morgan, Katy E ^a   Forbes, Andrew B ^b   Keogh, Ruth H ^a   Jairath, Vipul ^c   Kahan, Brennan C ^d  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

binary outcomes; cluster randomised; cross over; intra cluster correlation coefficient (ICC); randomised trial

Indexed keywords

CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSSOVER PROCEDURE; DRUG COMBINATION; ERROR; HUMAN; MODEL; RANDOMIZED CONTROLLED TRIAL; BIOSTATISTICS; BLOOD; CLUSTER ANALYSIS; COMPUTER SIMULATION; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; METABOLISM; ODDS RATIO; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGRESSION ANALYSIS; SAMPLE SIZE; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

HEMOGLOBIN;

BIOSTATISTICS; CLUSTER ANALYSIS; COMPUTER SIMULATION; CROSS-OVER STUDIES; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; HEMOGLOBINS; HUMANS; MODELS, STATISTICAL; ODDS RATIO; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 84989328979     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.7137     Document Type: Article

References (37)

1. Eldridge S, Kerry S. A Practical Guide to Cluster Randomised Trials in Health Services Research. Wiley: Chichester, 2012.
2. Rietbergen C, Moerbeek M. The design of cluster randomized crossover trials. JEBS 2011; 36(4): 472–490.
3. Reich NG, Milstone AM. Improving efficiency in cluster-randomized study design and implementation: taking advantage of a crossover. Open Access Journal of Clinical Trials 2014; 6: 11–15.
4. Arnup SJ, Forbes AB, Kahan BC, Morgan KE, McDonald S, McKenzie JE. The use of the cluster randomized crossover design in clinical trials: protocol for a systematic review. Systematic Reviews 2014; 3: 86.
5. Arnup SJ, Forbes AB, Kahan BC, Morgan KE, McKenzie JE. Appropriate statistical methods were infrequently used in cluster-randomized crossover trials: results from a systematic review. Journal of Clinical Epidemiology 2016; 74: 40–50.
6. Turner RM, White IR, Croudace T. Analysis of cluster randomized cross-over trial data: a comparison of methods. Statistics in Medicine 2007; 26: 274–289.
7. Parienti JJ, Kuss O. Cluster-crossover design: a method for limiting clusters level effect in community-intervention studies. Contemporary Clinical Trials 2007; 28: 316–323.
8. Forbes AB, Akram M, Pilcher D, Cooper J, Bellomo R. Cluster randomised crossover trials with binary data and unbalanced cluster sizes: application to studies of near-universal interventions in intensive care.Clinical Trials 2015; 12(1): 34–44.
9. StataCorp. Stata statistical software: release 13., 2013. College Station, TX: StataCorp LP.
10. Donner A, Klar N. Design and Analysis of Cluster Randomization Trials in Health Research. Arnold: New York, 2000.
11. Hayes RJ, Moulton LH. Cluster Randomised Trials. Chapman and Hall: Boca Raton, FL, 2009.
12. Murray DM. Design and Analysis of Group-Randomized Trials. Oxford University Press: New York, 1998.
13. Kahan BC, Morris TP. Assessing potential sources of clustering in individually randomised trials. BMC Medical Research Methodology 2013; 13: 58.
14. Eldridge SM, Ukoumunne OC, Carlin JB. The intra-cluster correlation coefficient in cluster randomized trials: a review of definitions. International Statistical Review 2009; 77: 378–394.
15. Wu S, Crespi CM, Wong WK. Comparison of methods for estimating the intraclass correlation coefficient for binary responses in cancer prevention cluster randomized trials. Contemporary Clinical Trials 2012; 33: 869–880.
16. Rabe-Hesketh S, Skrondal A. Multilevel and Longitudinal Modelling Using Stata ((2nd ed.)) Stata Press: College Station, Texas, 2008.
17. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988; 44: 1049–1060.
18. Neuhaus JM, Kalbfleisch JD, Hauck WW. A comparison of cluster-specific and population-averaged approaches for analyzing correlated binary data. International Statistical Review 1991; 59(1): 25–35.
19. StataCorp. Stata statistical software. Available from: http://www.stata.com/manuals13/xtxtgee.pdf [accessed November 2014].
20. Jones B, Kenward MG. Design and Analysis of Cross-over Trials ((2nd ed.)) Chapman and Hall/CRC: Boca Raton, FL, 2003.
21. Higgins JPT (ed.) SG. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2011. Version 5.1.0 [updated March 2011]. Available from: www.handbook.cochrane.org [accessed Novemeber 2015].
22. Ridout MS, Demétrio CG, Firth D. Estimating intraclass correlation for binary data. Biometrics 1999; 55: 137–148.
23. Donner A, Klar N, Zou G. Methods for the statistical analysis of binary data in split-cluster designs. Biometrics 2004; 60: 919–925.
24. Eldridge SM, Ashby D, Kerry S. Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method. International Journal of Epidemiology 2006; 35: 1292–1300.
25. White I. Simsum: analyses of simulation studies including Monte Carlo error. The Stata journal 2010; 10(3): 369–385.
26. Kenward MG, Roger JH. Small sample inference for fixed effects from restricted maximum likelihood. Biometrics 1997; 53(3): 983–997.
27. Kenward MG, Roger JH. An improved approximation to the precision of fixed effects from restricted maximum likelihood. Computational Statistics & Data Analysis 2009; 53(7): 2583–2595.
28. Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, Dyer C, Stokes EA, Llewelyn C, Bailey AA, Dallal H, Everett SM, James MW, Stanley AJ, Church N, Darwent M, Greenaway J, Le Jeune I, Reckless I, Campbell HE, Meredith S, Palmer KR, Logan RF, Travis SP, Walsh TS, Murphy MF. Restrictive vs liberal blood transfusion for acute upper gastrointestinal bleeding: rationale and protocol for a cluster randomized feasibility trial. Transfusion Medicine Reviews 2013; 27(3): 146–153.
29. Kahan BC, Jairath V, Murphy MF, Doré CJ. Update on the transfusion in gastrointestinal bleeding (TRIGGER) trial: statistical analysis plan for a cluster-randomised feasibility trial. Trials 2013; 14: 206.
30. Jairath V, Kahan BC, Gray A, Doré CJ, Mora A, James MW, Stanley AJ, Everett SM, Bailey AA, Dallal H, Greenaway J, Le Jeune I, Darwent M, Church N, Reckless I, Hodge R, Dyer C, Meredith S, Llewlyn C, Palmer KR, Logan RF, Travis SP, Walsh TS, Murphy MF. Restrictive versus liberal blood transfusion for acute upper gastrointestinal bleeding (TRIGGER): a pragmatic, open-label, cluster randomised feasibility trial. Lancet 2015; 386(9989): 137–144.
31. Giraudeau B, Ravaud P, Donner A. Sample size calculation for cluster randomized cross-over trials. Statistics in Medicine 2008; 27: 5578–5585.
32. Reich NG, Myers JA, Obeng D, Milstone AM, Perl TM. Empirical power and sample size calculations for cluster-randomized and cluster-randomized crossover studies. PLoS ONE 2012; 7(4): e35564. DOI: 10.1371/journal.pone.0035564.
33. Kahan BC. Bias in randomised factorial trials. Statistics in Medicine 2013; 32(26): 4540–4549.
34. Freeman PR. The performance of the two-stage analysis of two-treatment, two-period crossover trials. Statistics in Medicine 1989; 8(12): 1421–1432.
35. Shuster JJ. Diagnostics for assumptions in moderate to large simple clinical trials: do they really help?Statistics in Medicine 2005; 24(16): 2431–2438.
36. Taljaard M, Teerenstra S, Ivers NM, Fergusson DA. Substantial risks associated with few clusters in cluster randomized and stepped wedge designs. Clinical Trials 2016; 13(4): 459–463.
37. van Breukelen GJ, Candel MJ, Berger MP. Relative efficiency of unequal versus equal cluster sizes in cluster randomized and multicentre trials. Statistics in Medicine 2007; 26(13): 2589–2603.